Laurel Wealth Advisors (California)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,240
Closed -$415K 678
2022
Q1
$415K Sell
3,240
-100
-3% -$10.9K 0.03% 471
2021
Q4
$448K Buy
+3,340
New +$480K 0.03% 480

Other funds holding DXCM

Laurel Wealth Advisors (California)'s DXCM Position: Q2 2022 in Review

Laurel Wealth Advisors (California) sold out of DexCom (DXCM) in Q2 2022, closing a stake of 3,240 shares — an estimated $415K sold.

Laurel Wealth Advisors (California) first reported a position in DXCM in Q4 2021 and held it in 2 quarters. The position peaked at $448K in Q4 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Laurel Wealth Advisors (California) reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 3,240 DexCom shares in Q2 2022, an estimated $415K.
  • Laurel Wealth Advisors (California) first reported a position in DexCom in Q4 2021 and held it in 2 quarters.
  • Laurel Wealth Advisors (California)'s DexCom position peaked at $448K in Q4 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q2 2022, filed 12 Aug 2022.